METROPOLIS HEALTHCARE LTD (542650) — Latest Corporate Announcements
₹536.95
₹-1.60 (-0.30%)
Market Cap
₹11,139.24 Cr
P/E Ratio
56.28
52W Range
₹412.25 – ₹609.05
Corporate Actions & Regulatory Filings
Metropolis Healthcare Ltd - 542650 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Metropolis Healthcare Ltd - 542650 - Business Update For Q2FY27
Metropolis Healthcare Ltd - 542650 - Closure of Trading Window
Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Investor Presentation
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the audited financial results of the company for the quarter and financial year ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended December 31, 2025
To consider and approve the financial results for the period ended September 30, 2025 and dividend
To consider and approve the financial results for the period ended Jun 30, 2025
To consider and approve the financial results for the period ended March 31, 2025
To consider and approve the financial results for the period ended December 31, 2024
To consider and approve the financial results for the period ended September 30, 2024
To consider and approve the financial results for the period ended Jun 30, 2024
To consider and approve the Audited Standalone & Consolidated Financial Results for the period ended March 31, 2024
To consider and approve the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended December 31, 2023.
To consider and approve the financial results for the period ended September 30, 2023 and Interim dividend for the financial year 2023-24
To consider and approve the financial results for the period ended Jun 30, 2023
To consider and approve the financial results for the period ended March 31, 2023
Intimation of Notice of Board Meeting scheduled to be held on Friday, February 10, 2023
Financial Results (Quarterly & Annual)
| Quarter / Period | Meeting / Outcome Date | Status | Filing Details |
|---|---|---|---|
| Quarter Ended 30-Jun-2026 (Q1 FY27) | 04-Aug-2026 | Declared | To consider and approve the financial results for the period ended Jun 30, 2026 |
| Year Ended 31-Mar-2026 (Q4 FY26) | 13-May-2026 | Declared | To consider and approve the audited financial results of the company for the quarter and financial year ended March 31, 2026 and dividend |
| Quarter Ended 31-Dec-2025 (Q3 FY26) | 04-Feb-2026 | Declared | To consider and approve the financial results for the period ended December 31, 2025 |
| Quarter Ended 30-Sep-2025 (Q2 FY26) | 04-Nov-2025 | Declared | To consider and approve the financial results for the period ended September 30, 2025 and dividend |
| Quarter Ended 30-Jun-2025 (Q1 FY26) | 07-Aug-2025 | Declared | To consider and approve the financial results for the period ended Jun 30, 2025 |
| Year Ended 31-Mar-2025 (Q4 FY25) | 13-May-2025 | Declared | To consider and approve the financial results for the period ended March 31, 2025 |
| Quarter Ended 31-Dec-2024 (Q3 FY25) | 04-Feb-2025 | Declared | To consider and approve the financial results for the period ended December 31, 2024 |
| Quarter Ended 30-Sep-2024 (Q2 FY25) | 08-Nov-2024 | Declared | To consider and approve the financial results for the period ended September 30, 2024 |
| Quarter Ended 30-Jun-2024 (Q1 FY25) | 10-Aug-2024 | Declared | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Year Ended 31-Mar-2024 (Q4 FY24) (STD & CONSOL) | 21-May-2024 | Declared | To consider and approve the Audited Standalone & Consolidated Financial Results for the period ended March 31, 2024 |
| Quarter Ended 31-Dec-2023 (Q3 FY24) (STD & CONSOL) | 02-Feb-2024 | Declared | To consider and approve the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended December 31, 2023. |
| Quarter Ended 30-Sep-2023 (Q2 FY24) | 04-Nov-2023 | Declared | To consider and approve the financial results for the period ended September 30, 2023 and Interim dividend for the financial year 2023-24 |
Track Related Peer Equities
Related Research Guides & Regulatory Playbooks
Frequently Asked Questions about METROPOLIS HEALTHCARE LTD BSE Disclosures
What is the latest BSE announcement by METROPOLIS HEALTHCARE LTD?
The latest BSE disclosure by METROPOLIS HEALTHCARE LTD (METROPOLIS), filed on 2026-10-06T17:27:19, is: "Metropolis Healthcare Ltd - 542650 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018". Bsenexus tracks every official filing for METROPOLIS HEALTHCARE LTD with AI-powered summaries on its announcements feed.
When is METROPOLIS HEALTHCARE LTD's next board meeting?
No upcoming board meeting is currently tracked for METROPOLIS HEALTHCARE LTD. Companies disclose meeting intimations under SEBI LODR, and scheduled dates appear on the Bsenexus Results Calendar.
When does METROPOLIS HEALTHCARE LTD declare quarterly results?
Under SEBI (LODR) Regulation 33, listed companies submit quarterly unaudited results within 45 days of the quarter ending, and annual audited figures within 60 days. METROPOLIS HEALTHCARE LTD's recent results history is tabulated above. Track scheduled board meetings on the Bsenexus Results Calendar.